Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study

Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study

Summary: Background: Limited data exists regarding the efficacy of ChAdOx1-nCoV-19 vaccine against Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) in solid cancer patients. We aimed to assess the immunogenicity of the ChAdOx1-nCoV-19 vaccine and the impact of different anticancer thera...

Full description

Bibliographic Details
Main Authors: Nattaya Teeyapun, Sutima Luangdilok, Nussara Pakvisal, Panot Sainamthip, Siyamol Mingmalairak, Nattaya Poovorawan, Piyada Sitthideatphaiboon, Napa Parinyanitikul, Virote Sriuranpong, Teerayuth Namkanisorn, Pratchaya Inthasuwan, Pattama Angspatt, Ploytuangporn Wongchanapat, Akradach Bamrungnam, Nutchanok Leeleakpai, Sutheera Uttha, Supaporn Jaichum, Peerawich Kongkaew, Chayanin Suksanong, Rattiya Veranitinun, Ampai Prasomphol, Chada Sartsuk, Cheeraporn Patcharajutanon, Supreeya Preaprang, Hathairat Choengsamor, Rungthong Phongwan, Charoenpit Preeyasaksa, Ekkamol Phaibulvatanapong, Nungruthai Suntronwong, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Stephen J. Kerr, Yong Poovorawan, Passakorn Wanchaijiraboon, Suebpong Tanasanvimon
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:EClinicalMedicine
Subjects:
ChAdOx1-nCoV-19 vaccine
Immunogenicity
Cancer patients
Cancer treatments
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537022003388

Internet

http://www.sciencedirect.com/science/article/pii/S2589537022003388

Similar Items